Education
About Us
Working with TipRanks
Follow Us
Edwards Lifesciences (EW)
NYSE:EW
Earnings Data
Report Date
Feb 04, 2026After Close (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
0.62Last Year’s EPS
0.59Same Quarter Last Year
Moderate Buy
Based on 25 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
Edwards Lifesciences reported strong quarterly performance with significant sales growth across multiple segments, increased full-year guidance, and positive clinical data presentations. However, there were some concerns about declining gross profit margins and upcoming changes in financial leadership.Company Guidance
Double-Digit Sales Growth
Edwards Lifesciences reported a 12.6% increase in sales for the third quarter, reaching $1.55 billion, driven by a diverse portfolio across multiple therapeutic areas.
Increased Guidance for 2025
The company raised its full-year sales growth guidance to the high end of the previous 9% to 10% range, and also increased EPS guidance to between $2.56 and $2.62.
Strong TAVR Sales
Third quarter global sales of TAVR increased 10.6% year-over-year, reaching $1.15 billion, surpassing expectations.
TMTT Sales Surge
TMTT products saw sales of $144 million, a 53% increase year-over-year, driven by the PASCAL and EVOQUE systems.
Positive Clinical Data
Presentation of long-term data at TCT, including 7-year data for the PARTNER III trial and real-world registry data on EVOQUE, highlighting the durability and performance of Edwards' products.
Strong Balance Sheet
Edwards maintains approximately $3 billion in cash and cash equivalents, with an increased share repurchase authorization of $2 billion.
EW Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
EW Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Oct 30, 2025 | $83.48 | $82.45 | -1.23% |
Jul 24, 2025 | $75.80 | $80.00 | +5.54% |
Apr 23, 2025 | $70.46 | $75.13 | +6.63% |
Feb 11, 2025 | $70.91 | $75.82 | +6.92% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Edwards Lifesciences (EW) report earnings?
Edwards Lifesciences (EW) is schdueled to report earning on Feb 04, 2026, After Close (Confirmed).
What is Edwards Lifesciences (EW) earnings time?
Edwards Lifesciences (EW) earnings time is at Feb 04, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is EW EPS forecast?
EW EPS forecast for the fiscal quarter 2025 (Q4) is 0.62.